KLRF1, a novel marker of CD56(bright) NK cells, predicts improved survival for patients with locally advanced bladder cancer

BACKGROUND: Bladder tumor‐infiltrating CD56(bright) NK cells are more tumor cytotoxic than their CD56(dim) counterparts. Identification of NK cell subsets is labor‐intensive and has limited utility in the clinical setting. Here, we sought to identify a surrogate marker of bladder CD56(bright) NK cel...

Descripción completa

Detalles Bibliográficos
Autores principales: Mukherjee, Neelam, Ji, Niannian, Tan, Xi, Chen, Chun‐Liang, Noel, Onika D. V., Rodriguez‐Padron, Maria, Lin, Chun‐Lin, Alonzo, David G., Huang, Tim H., Svatek, Robert S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10134305/
https://www.ncbi.nlm.nih.gov/pubmed/36583228
http://dx.doi.org/10.1002/cam4.5579

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10134305/
https://www.ncbi.nlm.nih.gov/pubmed/36583228
http://dx.doi.org/10.1002/cam4.5579

Ejemplares similares